What is the current Biopsy Devices market size?

The current Biopsy Devices market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Biopsy Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing cancer cases.

What are the key drivers of the Biopsy Devices market?

Key drivers include rising demand for minimally invasive procedures and advancements in biopsy technologies.

What are the major challenges facing the Biopsy Devices market?

Major challenges include high costs associated with biopsy procedures and stringent regulatory frameworks.

Which regions are leading the Biopsy Devices market?

North America and Europe are currently leading the market, due to well-established healthcare infrastructure.

Who are the top companies in the Biopsy Devices market?

Top companies include Medtronic, Boston Scientific, and Abbott Laboratories, offering a range of biopsy devices.

What future opportunities exist in the Biopsy Devices market?

Future opportunities include emerging markets and the development of innovative, cost-effective biopsy devices.

How is technology impacting the Biopsy Devices market?

Advances in technologies, such as imaging-guided biopsies, are improving diagnosis accuracy and driving market growth.

What is the current regulatory landscape for the Biopsy Devices market?

The regulatory landscape is characterized by stringent FDA and CE mark approvals, ensuring device safety and efficacy.

Biopsy Devices Market Comprehensive Report: 200+ Pages | 2026–2034

Biopsy Devices by Application (Hospitals, Diagnostic Centres, Research Institutes, Other), by Types (Stereotactic X-Ray Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1852.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1852.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Biopsy Devices Market Size | CAGR 5.5% Forecast 2033

Biopsy Devices Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1852.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1852.5 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Biopsy Devices Market Overview

The Biopsy Devices market refers to the industry that manufactures and distributes devices used to collect tissue or cell samples for diagnostic purposes. As the global healthcare system continues to evolve, the Biopsy Devices market size is expected to reach $2.4 billion by 2026, with a growth outlook that is poised for significant expansion. The market forecast suggests a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of cancer, advancements in medical technology, and rising demand for minimally invasive procedures. The industry expansion is expected to be shaped by key forces such as technology shifts towards automated and robotic systems, regulations that emphasize patient safety and device efficacy, and consumer behavior that prioritizes non-invasive and pain-free procedures.

Loading chart…

The largest region in the Biopsy Devices market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and rising awareness about cancer diagnosis. The market is expected to be highly competitive, with key players such as Medtronic, Becton Dickinson, and Boston Scientific competing for market share. As the industry continues to evolve, it is essential for market players to stay ahead of the curve by investing in research and development, expanding their product portfolios, and establishing strategic partnerships to drive growth and expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.85 billion
Revenue forecast in 2033	3.23 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD Medical; Argon Medical; B. Braun Melsungen; Boston Scientific; C. R. Bard; Hologic; Cook Medical; INRAD; Devicor Medical Products; Planmed Oy; Stryker; Galini SRL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biopsy Devices market is experiencing significant growth, driven by various factors. Key growth drivers include:

Growth Drivers2 items

Advances in minimally invasive biopsy technologies, enabling faster and more accurate diagnoses, which is expected to contribute to the growth forecast of the Biopsy Devices market size

Increasing prevalence of cancers, such as breast, lung, and liver cancer, driving the demand for effective biopsy devices and contributing to the expansion of the Biopsy Devices market

However, the market also faces certain restraints that may hinder its growth. Restraints include:

Restraints2 items

High costs associated with advanced biopsy devices, making them inaccessible to low-income countries and limiting the growth of the Biopsy Devices market size

Stringent regulatory requirements, such as FDA approvals, which can delay the launch of new biopsy devices and impact the growth forecast of the Biopsy Devices market

The Biopsy Devices market also presents opportunities for growth and expansion. Opportunities include:

Opportunities2 items

Emerging markets, such as Asia Pacific, offering lucrative opportunities for biopsy device manufacturers to expand their customer base and increase the Biopsy Devices market size

Increasing adoption of liquid biopsy technologies, which is expected to drive the growth of the Biopsy Devices market and contribute to its growth forecast

Finally, the Biopsy Devices market faces challenges that need to be addressed. Challenges include:

Challenges2 items

Intense competition among biopsy device manufacturers, leading to pricing pressures and reduced profit margins, which can impact the growth of the Biopsy Devices market size

Need for continuous innovation to stay ahead of the competition and address evolving customer needs, which is crucial for the growth forecast of the Biopsy Devices market

Market Segmentation

Loading chart…

The Biopsy Devices market can be segmented based on Application, which includes subtypes such as breast biopsy, lung biopsy, liver biopsy, and kidney biopsy. This segmentation contributes to the overall Biopsy Devices market size by providing insights into the specific areas where biopsy devices are used. Understanding the application segment is crucial for market players to develop targeted strategies and products. The Biopsy Devices segmentation by application helps in identifying the most prominent areas of use, enabling companies to allocate resources effectively.

The Types of biopsy devices include subtypes such as needle-based biopsy devices, core needle biopsy devices, and vacuum-assisted biopsy devices. This segmentation is essential in understanding the different types of devices used for biopsy procedures. Each type of device has its own set of characteristics, advantages, and limitations, which influence the overall Biopsy Devices market. Analyzing the types of biopsy devices helps in understanding the market trends, technological advancements, and consumer preferences, ultimately contributing to the growth of the Biopsy Devices market.

Biopsy Devices Segmentation Breakdown9 items

Application

Hospitals

Diagnostic Centres

Research Institutes

Other

Types

Stereotactic X-Ray Guided Biopsy

Ultrasound Guided Biopsy

MRI Guided Biopsy

Regional Insights

Loading chart…

The Biopsy Devices market growth is projected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The Asia Pacific region is expected to be the fastest-growing region, driven by increasing adoption of advanced biopsy devices, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for the North America region include a mature ecosystem, high demographics of cancer patients, and advanced infrastructure. In Europe, the key drivers are adoption of minimally invasive biopsy procedures, policies supporting cancer research, and a well-established ecosystem. The Asia Pacific region is driven by investments in healthcare, increasing adoption of digital pathology, and a large patient pool.

In Latin America, the key drivers are infrastructure development, government policies supporting healthcare, and growing demographics of cancer patients. The Middle East & Africa region is driven by adoption of advanced medical technologies, investments in healthcare infrastructure, and a growing patient pool. These regional factors are expected to influence the regional forecast of the Biopsy Devices market.

Competitive Landscape

The Biopsy Devices market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Biopsy Devices competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players tend to dominate the market, while local companies focus on regional expansion and localization.

Companies in the Biopsy Devices market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

BD Medical: regional expansion

Argon Medical: premium pricing

B. Braun Melsungen: innovation pipeline

Boston Scientific: OEM tie-ups

C. R. Bard: local manufacturing

Hologic: vertical integration

Key Biopsy Devices Companies12 items

BD Medical

Argon Medical

B. Braun Melsungen

Boston Scientific

C. R. Bard

Hologic

Cook Medical

INRAD

Devicor Medical Products

Planmed Oy

Stryker

Galini SRL

Market Ecosystem

The Biopsy Devices ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of biopsy devices, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The ecosystem boundaries are defined by the interactions among these segments, from raw material suppliers to end users, with each playing a distinct role in the value chain analysis.

Raw material suppliers — provide components for device manufacturing

OEMs / manufacturers — design and produce biopsy devices

System integrators / EPCs — assemble and test devices

Distributors / channel partners — supply devices to healthcare facilities

Service providers / after-sales — offer maintenance and support services

End users / buyers — healthcare professionals and institutions

Regulators/standards bodies — establish guidelines and approval processes

The flow of value within the Biopsy Devices ecosystem is influenced by control points, such as regulatory approvals and adoption by healthcare institutions. Dependency risks, including input constraints and standards compliance, can impact the ecosystem's efficiency. Switching costs, partnerships, and interoperability requirements also affect the dynamics among ecosystem participants. Furthermore, regional differences in healthcare infrastructure, regulations, and market demands can lead to variations in the ecosystem's structure and value flow across different regions.

Recent Industry Insights

The Biopsy Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading medical device manufacturers and research institutions, have focused on developing innovative biopsy technologies. Additionally, there have been notable mergers and acquisitions, with key players expanding their product portfolios and strengthening their market presence. Several companies have also launched new products and technologies, including advanced imaging-guided biopsy systems and minimally invasive devices.

Furthermore, regulatory changes have played a crucial role in shaping the Biopsy Devices industry, with updated guidelines and standards influencing product development and approval processes. The industry has also seen a shift in consumer and enterprise trends, with an increasing emphasis on personalized medicine and point-of-care diagnostics. Funding rounds and expansions have supported the growth of start-ups and small businesses, driving innovation and competition in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Biopsy Devices market. The market attractiveness is moderate, driven by increasing cancer incidence and advancements in diagnostic technologies. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook for the Biopsy Devices market outlook is promising, with a growing demand for minimally invasive procedures.

Innovation in the biopsy devices space is focused on improving accuracy, reducing complications, and enhancing patient comfort. The demand-supply balance is expected to remain stable, with manufacturers expanding their production capacities to meet growing demand. However, key risk factors include stringent regulatory requirements and intense competition, which may impact market growth.

11 items

1. Executive Summary

2. Biopsy Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biopsy Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Diagnostic Centres

6.1.3. Research Institutes

6.1.4. Other

6.2. Global Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Stereotactic X-Ray Guided Biopsy

6.2.2. Ultrasound Guided Biopsy

6.2.3. MRI Guided Biopsy

6.3. Global Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Biopsy Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biopsy Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biopsy Devices Market Competition by Key Manufacturers

8.1. Global Biopsy Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Biopsy Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Argon Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun Melsungen

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Boston Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. C. R. Bard

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hologic

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cook Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. INRAD

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Devicor Medical Products

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Planmed Oy

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Stryker

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Galini SRL

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biopsy Devices Market

Figure 4: Global Biopsy Devices Market: Drivers

Figure 5: Global Biopsy Devices Market: Challenges

Figure 6: Global Biopsy Devices Market: Trends

Figure 7: Global Biopsy Devices Market: Opportunity

Figure 8: Global Biopsy Devices Market: Restraint

Figure 9: Global Biopsy Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Biopsy Devices Market Value (USD Million) By Region

Figure 15: Global Biopsy Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Biopsy Devices Market Value (USD Million) By Region

Figure 23: Global Biopsy Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Biopsy Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biopsy Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biopsy Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Biopsy Devices Market Value (USD Million) By Region

Table 10: Global Biopsy Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Biopsy Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Biopsy Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Biopsy Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Medical Basic Information And Sales Area

Table 31: BD Medical. Products Portfolio

Table 32: Argon Medical Basic Information And Sales Area

Table 33: Argon Medical. Products Portfolio

Table 34: B. Braun Melsungen Basic Information And Sales Area

Table 35: B. Braun Melsungen. Products Portfolio

Table 36: Boston Scientific Basic Information And Sales Area

Table 37: Boston Scientific. Products Portfolio

Table 38: C. R. Bard Basic Information And Sales Area

Table 39: C. R. Bard. Products Portfolio

Table 40: Hologic Basic Information And Sales Area

Table 41: Hologic. Products Portfolio

Table 42: Cook Medical Basic Information And Sales Area

Table 43: Cook Medical. Products Portfolio

Table 44: INRAD Basic Information And Sales Area

Table 45: INRAD. Products Portfolio

Table 46: Devicor Medical Products Basic Information And Sales Area

Table 47: Devicor Medical Products. Products Portfolio

Table 48: Planmed Oy Basic Information And Sales Area

Table 49: Planmed Oy. Products Portfolio

Table 50: Stryker Basic Information And Sales Area

Table 51: Stryker. Products Portfolio

Table 52: Galini SRL Basic Information And Sales Area

Table 53: Galini SRL. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Biopsy Devices Market Value (USD Million) By Region

Table 59: Global Biopsy Devices Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biopsy Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.85 billion
Revenue forecast in 2033	3.23 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD Medical; Argon Medical; B. Braun Melsungen; Boston Scientific; C. R. Bard; Hologic; Cook Medical; INRAD; Devicor Medical Products; Planmed Oy; Stryker; Galini SRL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options